Dr. Apseloff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
206 E State St
Columbus, OH 43215Phone+1 614-224-2235Fax+1 614-224-2267
Education & Training
Mount Carmel Health SystemInternship, Transitional Year, 1986 - 1987
Ohio State University College of MedicineClass of 1986
Certifications & Licensure
OH State Medical License 1987 - 2025
Clinical Trials
- Intravenous Dose-Escalation Study With ETI-204 in Adult Volunteers Start of enrollment: 2009 Feb 01
- Normative Data Base of Brain Network Activation (BNA) Using Evoked Response Potentials Start of enrollment: 2015 Mar 01
Publications & Presentations
PubMed
- Time Course of Reversal of Fentanyl-Induced Respiratory Depression in Healthy Subjects by Intramuscular Nalmefene and Intramuscular and Intranasal Naloxone.Alessandra Cipriano, Glen Apseloff, Ram P Kapil, Ellie He, Manjunath Shet
Journal of Clinical Pharmacology. 2024-09-30 - Evaluation of sunobinop for next-day residual effects in healthy participants.Alessandra Cipriano, Ram P Kapil, Mingyan Zhou, Manjunath S Shet, Stephen C Harris
Frontiers in Pharmacology. 2024-01-01 - 5 citationsThe novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users.Megan J Shram, Jack E Henningfield, Glen Apseloff, Charles W Gorodetzky, Sara De Martin
Translational Psychiatry. 2023-06-07
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
